We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$988M
AUM Growth
-$950M
Cap. Flow
-$941M
Cap. Flow %
-95.22%
Top 10 Hldgs %
46.58%
Holding
205
New
16
Increased
16
Reduced
38
Closed
131

Top Buys

Rank Stock Value
1
QTRX icon
Quanterix
QTRX
+$23.5M
2
OM icon
Outset Medical
OM
+$11.4M
3
LIVN icon
LivaNova
LIVN
+$8.76M
4
CUTR
Cutera, Inc.
CUTR
+$5.89M
5
RCM
R1 RCM Inc. Common Stock
RCM
+$4.31M

Top Sells

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$26.8M
2
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$25.3M
3
BIIB icon
Biogen
BIIB
+$17.4M
4
ESTA icon
Establishment Labs
ESTA
+$15.9M
5
VRAY
ViewRay, Inc.
VRAY
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 31.61%
2 Industrials 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTKB icon
101
Cytek Biosciences
CTKB
$621M
– –
-420,749
Closed -$4.3M
CVAC
102
CALL
DELISTED
CureVac
CVAC
– –
-100,000
Closed -$603K
CVAC
103
DELISTED
CureVac
CVAC
– –
-128,245
Closed -$774K
CVS icon
104
PUT
CVS Health
CVS
$121B
– –
-100,000
Closed -$9.32M
DHR icon
105
PUT
Danaher
DHR
$145B
– –
-73,320
Closed -$17.3M
DXCM icon
106
DexCom
DXCM
$34.3B
– –
-71,139
Closed -$8.06M
ELV icon
107
PUT
Elevance Health
ELV
$86.6B
– –
-20,000
Closed -$10.3M
EOLS icon
108
Evolus
EOLS
$536M
– –
-50,000
Closed -$376K
ESPR
109
DELISTED
Esperion Therapeutics
ESPR
– –
-308,313
Closed -$1.92M
ESTA icon
110
CALL
Establishment Labs
ESTA
$2.25B
– –
-25,000
Closed -$1.64M
ETNB
111
CALL
DELISTED
89bio
ETNB
– –
-51,000
Closed -$649K
ETNB
112
DELISTED
89bio
ETNB
– –
-50,000
Closed -$637K
EVAX
113
Evaxion A/S
EVAX
$25.6M
– –
-337
Closed -$29.9K
EXAS
114
CALL
DELISTED
Exact Sciences
EXAS
– –
-275,000
Closed -$13.6M
EXEL icon
115
Exelixis
EXEL
$12.5B
– –
-75,000
Closed -$1.2M
GERN icon
116
CALL
Geron
GERN
$1.01B
– –
-1,814,600
Closed -$4.39M
GERN icon
117
PUT
Geron
GERN
$1.01B
– –
-623,300
Closed -$1.51M
GH icon
118
CALL
Guardant Health
GH
$22.2B
– –
-408,900
Closed -$11.1M
GH icon
119
Guardant Health
GH
$22.2B
– –
-426,874
Closed -$11.6M
CBIO
120
CALL
Crescent Biopharma
CBIO
$610M
– –
-1,766
Closed -$535K
CBIO
121
Crescent Biopharma
CBIO
$610M
– –
-316
Closed -$95.8K
HOLX
122
PUT
DELISTED
Hologic
HOLX
– –
-105,400
Closed -$7.88M
HSIC icon
123
PUT
Henry Schein
HSIC
$10.1B
– –
-140,000
Closed -$11.2M
HUM icon
124
PUT
Humana
HUM
$46.7B
– –
-20,000
Closed -$10.2M
IDXX icon
125
PUT
Idexx Laboratories
IDXX
$45B
– –
-20,000
Closed -$8.16M
3 4
5
6 7

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2023 Portfolio in Review

As of Q1 2023, Pura Vida Investments held 205 positions worth $988M, down 49% from $1.94B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Pura Vida Investments withdrew a net $941M in Q1 2023, closing 131 positions and reducing 38 holdings. Its most notable exit was IVERIC bio, Inc. Common Stock, an estimated $25.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Industrials.

Against the trend, Pura Vida Investments opened a new position in Repligen worth $2.56M.

  • Pura Vida Investments's largest Q1 2023 buy was Repligen: 15,200 shares worth $2.56M.
  • Pura Vida Investments added most to Quanterix in Q1 2023, an estimated $23.5M increase.
  • Pura Vida Investments's biggest Q1 2023 reduction was Inspire Medical Systems, cutting an estimated $26.8M.
  • Pura Vida Investments fully exited IVERIC bio, Inc. Common Stock in Q1 2023, selling an estimated $25.3M.
  • Pura Vida Investments's ten largest holdings make up 47% of its $988M portfolio in Q1 2023.
  • Pura Vida Investments opened 16 new positions and closed 131 in Q1 2023.
  • Pura Vida Investments's portfolio value fell 49% quarter-over-quarter to $988M.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.